Why does my life insurance application keep getting delayed for lab results?

For life insurance carriers and Managing General Agents (MGAs), the underwriting pipeline is a critical operational workflow. Yet, it is often plagued by a persistent bottleneck: the paramedical exam and its associated laboratory testing. While teams focus on optimizing application forms and digital portals, the multi-week waiting period for blood and urine analysis remains a major source of friction. This delay not only frustrates applicants, increasing the likelihood of abandonment, but also extends the time-to-coverage, impacting business metrics and creating a poor customer experience. The core issue is a dependency on a physical, fluid-based evidence-gathering process in an increasingly digital world, a problem that directly contributes to a life insurance approval delay due to lab results.

"Accelerated underwriting programs can reduce the time to a final decision to an average of 9 days, compared to 27 days for traditional underwriting, with the primary bottleneck being the collection and analysis of fluid-based lab work."

The anatomy of a lab-induced underwriting delay

The traditional life insurance application process has remained largely unchanged for decades. After submitting an application, the majority of applicants must undergo a paramedical exam. This involves a third-party examiner visiting the applicant's home or office to collect physiological data, including blood and urine samples. These samples are then shipped to a laboratory for analysis. This is where the most significant and unpredictable delays occur.

A life insurance approval delay lab results from a multi-step logistical chain that includes:

• Scheduling: Coordinating a time that works for both the applicant and the paramedical examiner can take days or even weeks.
• Sample Collection: The appointment itself is a point of friction, requiring the applicant to be available for 30-60 minutes.
• Transportation: Samples are physically transported to a central lab, introducing risks of shipping delays or sample degradation.
• Lab Processing: Once at the lab, samples are queued for analysis. Depending on the lab's current volume and the specific tests required (e.g., blood lipids, glucose, cotinine), this can take several business days.
• Result Transmission: The results are then sent back to the insurance carrier's underwriting department.
• Underwriter Review: Finally, an underwriter must manually review the lab results in conjunction with the application and other data sources like an Attending Physician Statement (APS).

Any issue along this chain can add significant time. A lost sample, an abnormal result requiring further investigation, or a simple backlog at the lab can turn a four-week process into a six- or eight-week ordeal.

Comparing underwriting data collection methods

The emergence of contactless health assessment technologies, particularly those using remote photoplethysmography (rPPG), presents a fundamental shift away from the fluid-based model. This technology allows carriers to gather critical health indicators using only the camera on an applicant's smartphone, eliminating the entire paramedical exam and lab testing process.

Feature	Traditional Paramedical Exam	Contactless Vitals Assessment
Time to Results	1-3 weeks	< 2 minutes
Applicant Experience	Invasive, requires scheduling, 30-60 min appointment	Non-invasive, on-demand, 30-90 second scan
Logistics	Examiner scheduling, sample shipping, lab processing	None; fully digital data capture and delivery
Data Points	Blood pressure, pulse, height/weight, blood/urine biomarkers	Blood pressure, pulse, heart rate variability (HRV), stress
Cost Per Applicant	$125 - $250+	Significantly lower, purely software-based cost
Fraud Potential	Moderate (e.g., applicant substitution)	Low (includes liveness detection)

Industry applications of contactless assessment

For carriers and MGAs looking to accelerate their underwriting process, contactless vitals assessment offers several strategic advantages. It's not just about replacing the paramedical exam; it's about re-engineering the workflow for speed and efficiency.

For accelerated underwriting (au) programs

Contactless vitals can serve as a powerful triage tool. Low-risk applicants can be fast-tracked for instant or near-instant approval, while those with elevated readings can be seamlessly routed to a more traditional workflow or a human underwriter for review. This allows carriers to approve a larger percentage of applicants without collecting fluids.

For group and voluntary benefits

In the group life and voluntary benefits space, the economics of individual paramedical exams are often prohibitive. Contactless assessments provide a scalable and cost-effective way to gather evidence of insurability (EOI) for large groups, enabling more accurate risk stratification without the logistical burden.

Reducing application abandonment

The primary driver of application abandonment is process friction. By providing an instant, on-demand health screening that can be completed from anywhere, carriers can significantly reduce the drop-off rate associated with scheduling and waiting for exam results.

Current research and evidence

The technology underpinning contactless assessment, rPPG, has been the subject of extensive academic research. Studies have validated its accuracy against traditional medical devices. For instance, a clinical validation study involving cardiovascular disease patients published in the Journal of Medical Internet Research (Wannenburg et al., 2023) found a strong agreement between rPPG-derived pulse rate and ECG readings, with a mean absolute error of just 1.061 bpm. Research has also demonstrated high degrees of accuracy for other key vitals like respiratory rate. As research continues, the range of biomarkers and health indicators that can be reliably measured via a camera is expected to expand, further increasing the value of this data for mortality risk assessment.

The future of underwriting: beyond the lab

The shift away from fluid-based testing is a definitive trend in life insurance. As consumer expectations for digital-first experiences grow, the pressure to eliminate the delays and friction of paramedical exams will intensify. Carriers who adopt contactless technologies will gain a significant competitive advantage in speed, cost, and customer experience. This allows underwriters to focus their expertise on complex cases rather than managing the logistics of data collection. The future of underwriting lies in using digital data streams to make faster, more informed decisions, and moving beyond the constraints of the physical lab is the first and most critical step.

Frequently asked questions

Q: Does eliminating the lab test mean we are taking on more risk? A: Not necessarily. Contactless vitals assessment provides a new set of data points, like heart rate variability (HRV), that are powerful predictors of mortality risk. The goal is not to collect less information, but to collect more predictive information faster. This data can be used to triage applicants, confidently approving low-risk individuals while flagging higher-risk cases for deeper review.

Q: How does this technology handle potential fraud? A: Modern contactless assessment platforms incorporate liveness detection and other anti-fraud measures. These systems can verify that they are measuring a live person and not a photo or video, making them more secure than a traditional paramedical exam where applicant substitution is a known risk.

Q: What is the integration effort for a carrier's existing application system? A: Most contactless vitals solutions are designed to be integrated via an API or SDK. This allows carriers to embed the health scan directly into their existing digital application workflow. The applicant experience is seamless; they are simply prompted to complete the scan on their device, and the results are posted directly to the underwriting workbench.

Q: Can this technology replace all paramedical exams? A: While contactless assessment can replace the paramedical exam for a large percentage of the applicant pool, high-value policies or applicants with significant pre-existing conditions may still require traditional evidence. The key is to use contactless technology to segment the applicant population, allowing the majority to bypass the exam and accelerate to approval, freeing up resources to focus on the complex cases that truly require it.

For life insurance carriers and MGA/MGUs, the persistent challenge of life insurance approval delay lab results represents a significant opportunity for innovation. The technology to eliminate this bottleneck and fundamentally accelerate underwriting is no longer theoretical. Circadify is at the forefront of this shift, providing the contactless assessment tools to help carriers modernize their underwriting workflows. To see how this technology can reduce your cycle times and improve applicant completion rates, explore our case studies and ROI calculators at circadify.com/industries/payers-insurance.